The current status of neurotensin-dopamine interactions. Issues and speculations

Ann N Y Acad Sci. 1992:668:232-52. doi: 10.1111/j.1749-6632.1992.tb27353.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Axons / metabolism
  • Brain / metabolism*
  • Cerebral Cortex / chemistry
  • Cerebral Cortex / metabolism
  • Corpus Striatum / metabolism
  • Dopamine / chemistry
  • Dopamine / metabolism*
  • Dopamine Antagonists
  • Dopamine D2 Receptor Antagonists
  • Electrophysiology
  • Gene Expression / drug effects
  • Mesencephalon / chemistry
  • Mesencephalon / physiology
  • Neurons / chemistry
  • Neurons / physiology
  • Neurotensin / analysis
  • Neurotensin / biosynthesis
  • Neurotensin / chemistry
  • Neurotensin / metabolism*
  • Oxidopamine / pharmacology
  • Receptors, Dopamine D1 / antagonists & inhibitors
  • Receptors, Dopamine D1 / metabolism
  • Receptors, Dopamine D2 / metabolism
  • Receptors, Neurotensin
  • Receptors, Neurotransmitter / chemistry
  • Reserpine / pharmacology
  • Tyrosine 3-Monooxygenase / chemistry
  • Tyrosine 3-Monooxygenase / genetics
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Dopamine Antagonists
  • Dopamine D2 Receptor Antagonists
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Receptors, Neurotensin
  • Receptors, Neurotransmitter
  • Neurotensin
  • Reserpine
  • Oxidopamine
  • Tyrosine 3-Monooxygenase
  • Dopamine